ÂÜÀòÂÒÂ×

Amy Zhang has diverse cross functional experience from over 20+ years in small and large pharmaceutical companies with an established tracking record of clinical and regulatory success within the pharmaceutical industry. Her experiences include strategic planning, executing, and reporting clinical pharmacology and clinical studies from Phase 1 to Phase 3. She had direct experiences in 60+ international and domestic clinical trials. She has worked on numerous NDAs/BLAs, INDs, IMPDs, MAAs, and other regulatory documents, plus client representation at FDA and EMA meetings including advisory board meetings and EU hearings. She received her PhD in Clinical Pharmacokinetics from the University of Witten/Herdecke and MD from Shanxi Medical University.